Publication

KEYNOTE-086 cohort B: pembrolizumab monotherapy for PD-L1–positive, previously untreated, metastatic triple-negative breast cancer (mTNBC).

Adams, S
; 
Loi, S
; 
Toppmeyer, D
; 
Cescon, D
; 
De Laurentiis, M
; 
Nanda, R
; 
Winer, E
; 
Mukai, H
; 
Tamura, K
; 
Armstrong, Anne C
... show 10 more
Citations
Altmetric:
Abstract
Authors
Adams, S
Loi, S
Toppmeyer, D
Cescon, D
De Laurentiis, M
Nanda, R
Winer, E
Mukai, H
Tamura, K
Armstrong, Anne C
Liu, M
Iwata, H
Ryvo, L
Wimberger, P
Rugo, H
Tan, A
D'Aquanno, C
Ding, Y
Karantza, V
Schmid, P
Affiliation
Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY
Description
Date
2018-02-14
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Meetings and Proceedings
Citation
KEYNOTE-086 cohort B: pembrolizumab monotherapy for PD-L1–positive, previously untreated, metastatic triple-negative breast cancer (mTNBC). 2018, 78(4 Suppl): PD6-10 Cancer Res
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620932
Embedded videos